Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0347|37|5|722-726

ISSN： 1043-3074

Source： HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol.37, Iss.5, 2015-05, pp. : 722-726

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 2, 2015-02 ,pp. : 182-187

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adenoid Cystic Carcinoma: Clinical and Molecular Features

By Moskaluk Christopher  

Head and Neck Pathology, Vol. 7, Iss. 1, 2013-03 ,pp. : 17-22

Humana Press, Inc

Access to resources Recommend Favorite

Efficacy of Bevacizumab plus Erlotinib for Advanced Hepatocellular Carcinoma and Predictors of Outcome: Final Results of a Phase II Trial

By  

Oncology, Vol. 82, Iss. 2, 2012-02 ,pp. : 67-74

Karger

Access to resources Recommend Favorite

Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO – #077

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 162, Iss. 2, 2013-07 ,pp. : 202-209

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adenoid Cystic Carcinoma of the Skin

By  

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 3, 1993-03 ,pp. : 164-170

John Wiley & Sons Inc

Access to resources Recommend Favorite